Key words: dopamine release -striatum -amphetamine -DOPAC -superfusion system -endogenous neurotransmitter release -dopamine An easily constructed, inexpensive and simple system is described for the superfusion of neural tissue. To characterize the system, the dynamics of endogenous dopamine and dihydroxyphenylacetic acid release from striatal tissue were studied before and after exposure to potassium, amphetamine or cocaine.
Introduction
In vitro superfusion systems for studying endogenous neurotransmitter release, rather than radiolabeiled transmitter release, have many advantages over other methods (Becker and Ramirez, 1980; Mulder, 1982) . Unfortunately, endogenous transmitter release is not commonly measured, perhaps in part due to the considerable experience, manual dexterity, and patience required to operate previous systems (Becker and Ramirez, 1980) . We report here a simple chamber design that can be inexpensively constructed from materials readily available in most laboratories. Eight of these chambers can be simultaneously operated with ease, and technical problems are minimal with proper maintenance. Significant changes from the previously reported methods (Becker and Ramirez, 1980) in the size of the chamber and in the superfusion medium required that a series of experiments be conducted to characterize striatal dopamine (DA) release using this system.
Methods

Superfusion medium
A modified Krebs-Ringer phosphate medium with a final composition of: 120 mM NaC1, 4.8 mM KC1, 1.25 mM CaCI2-2H20, 1.2 mM MgSO 4, 15 mM phosphate buffer, 0.1% bovine serum albumin and 10 mM D-glucose, was used in all experiments. When 60 mM potassium (K +) was added to the medium the sodium concentration was reduced to 65 mM. When calcium was omitted from the medium sodium was increased to 121.2 mM. The medium was oxygenated by bubbling 95% 02 : 5% CO 2 through it for 15 rain with continuous stirring. The pH of the medium was then adjusted to 7.4.
Tissue preparation
Adult male Holtzman rats (Madison, Wisc.) were killed by decapitation and the brains removed. The right and left striata were dissected separately (see Becker and Ramirez, 1980) and placed in individual beakers of ice cold medium (maximum time = 2.5 min from decapitation to completion of the dissection). The tissue was then transferred to a glass Petri dish containing enough ice-cold medium to keep the tissue wet, and a razor blade was used to chop the tissue into approximately l-ram 3 pieces. Each striatum was then placed into an individual superfusion chamber ( Fig.  1 ) that contained medium warmed to 37 ° C. At the conclusion of each superfusion, the tissue was removed from the chamber and weighed. The average amount of tissue in each chamber was 40.9 _+ 1.0 mg (n = 83).
Superfusion system
The superfusion system is schematically represented in Fig. 1 . The chambers (Fig.  1A ) are constructed from 1-ml disposable allergist syringes (Becton-Dickinson, Rutherford, N J). The barrel of each syringe is cut in cross-section producing a calibrated open tube 3.5 cm long. The bottom of the tube is sealed with the black stopper obtained from the syringe plunger (tip up) and a rubber cap. At the end of each superfusion the rubber cap can be removed and the black stopper used to gently push the tissue out the top of the chamber.
Medium is pumped through tygon tubing ( Fig. 1 B) by an 8-channel Technichron AutoAnalyzer Proportioning Pump at a rate of 100/~l/min. The medium enters the chamber via a length of 18-gauge stainless steel hypodermic tubing that passes through a black stopper sealing the top of the chamber (also constructed from the end of a syringe plunger). The stainless steel tubing protrudes 8 mm from the stopper and is held in place by a dollop of solder (black oval in top stopper, in the chamber at 200 /~1. This exit tubing makes a 90 ° bend and then pierces a rubber plug located on the bottom of the water bath (Fig. 1D) . The exit tubing is held in place by silicone adhesive liberally applied around the exit hole. It is also glued to a plastic ring that is constructed from the top of the syringe (not shown) that bridges the chamber wall and exit tubing near the bottom of the chamber. The day before each superfusion, the chamber is checked for any leaks in the seals and re-glued if necessary. In developing this chamber we tested many other designs that had the entrance and exit tubing located in a variety of configurations (e.g. medium entering the top and exiting the bottom or vice versa). A dye was pumped through the system in each case to determine how thoroughly the entering medium mixed with the medium in the chamber. With the design shown in Fig. 1 dye could be seen to mix with liquid throughout the chamber. In contrast, when the dye entered from a tube in the bottom and exited the top, it formed a channel of dye through the center and did not mix well with the surrounding liquid.
The medium in the chamber is warmed because the chambers are located in a water bath maintained at 37°C by a circulating heater (Fig. 1C ). In addition, the tygon tubing passes through the water, warming the medium prior to entering the chamber. With this set-up we routinely use 8 chambers simultaneously.
In pilot experiments in which sample collection started 25 min after the superfusion had begun, the spontaneous efflux of endogenous DA and DOPAC from striatal tissue decreased exponentially (r=-0.967 log time vs log DA release, P < 0.001; r = -0.968 logtime vs log DOPAC release, P < 0.001). Therefore, sample collection began 1 h after the tissue was placed in the chambers when the spontaneous efflux of DA was approaching asymptote. Effluent was always collected on ice over 5 rain intervals, in tubes containing 25 ~1 of: 0.05 N HCIO4~ 1 /~M EDTA. 40 /~M NaHSO4 and 0.02% dihydroxybenzylamine (DHBA) as an internal standard. Samples were stored frozen at -20°C for up to 4 days prior to being assayed.
The time required for the medium to reach the chambers from the inlet was calculated by recording the latency for an air bubble, introduced at the inlet, to reach the chamber. With this information, an experimental solution could be introduced by transferring the inlet ends of the tubing to a beaker containing the experimental solution (leaving a small air bubble to mark where the new solution began) at the appropriate time. At the end of the stimulation period, the tubing was returned to the beaker with normal medium, again marking with a small air bubble.
Catecholamine assay DA and DOPAC concentrations in the effluent were measured by high performance liquid chromatography with electrochemical detection (HPLC-EC). Brownlee RP-18 (reverse phase, C-18, 5-/~m particles) columns were used. The mobile phase was a 0.1 M citrate-phosphate (3:2) buffer containing 0.1 mM EDTA, methanol and sodium octyl sulfate with an apparent pH of 3.35. The amount of methanol varied from 6 to 15% and sodium octyl sulfate from 30 to 400 mg/1, depending upon the column and its age. The electrochemical detector (LC-4A, BioAnalytical Systems, Lafayette, IN) employed a glassy carbon electrode with a potential of + 0.74 V against a Ag/AgC1 reference electrode. The detector sensitivity was set at 5 nA/V. Under these conditions 20 /~1 of the acidified effluent was injected (Rheodyne Injection Valve, Berkeley, CA) without further preparation. Standards of known concentrations of DA and DOPAC were prepared in the medium and a 4 point standard curve was obtained for each assay. The standard curve for DA was linear from 50 to 2000 pg, and for DOPAC from 50 to 1000 pg. All samples fell within these ranges (see Fig. 2 ). Endogenous DA and DOPAC release rates were expressed as pg/mg tissue/rain.
K + -stimulated release
After the 1-h stabilization period baseline effluent samples were collected at 5 rain intervals for 20 rain. Medium containing 60 mM KCI was then infused for 30 s, 1 min, 2 rain, 3 min, 4 min or 5 min (n = 4/group) and 5-rain samples collected for an additional 20 rain. Due to the rapid mixing of 60 mM KCI with the contents of the chamber the effective concentration after a 30 s infusion duration was 20 mM KC1 (50/~l of 60 mM KCI in a total volume of 150 ~1, assuming tissue displacement of 50 /~1) and after 60 s infusion, the effective dose was 40 mM KCI.
Repeated 60 mM K + -stimulation
To determine if striatal tissue retained its responsiveness following repeated stimulation, 60 mM K + was infused for 2.5 rain at the beginning of the 5th, 9th and 13th 5 rain intervals (n = 8 superfusions).
Amphetamine (A MPH)-stimulated release
Effluent samples were collected for 14 5-min intervals. Medium containing l0 7, 
Calcium dependence
To determine if AMPH and/or K+-stimulated DA or DOPAC release was calcium-dependent the right striatum was placed in normal medium (n = 4) and the left in calcium-free medium (n = 4). Following the 1-h stabilization period samples were collected for twelve 5-min intervals. Medium containing l0 5 M AMPH was infused for 2.5 min at the beginning of the 5th interval, and medium containing 60 mM K + infused for 2.5 rain at the beginning of the 10th interval.
Temperature dependence
Superfusion chambers were positioned in an ice bath maintained at 0 °C and the medium cooled to 0-4°C. After 1 h, samples were collected at 5-rain intervals. Medium containing 10 5 M AMPH was infused for 2.5 min at the beginning of the 5th interval, and 60 mM K + infused for 2.5 rain during the 10th interval,
Cocaine-stimulated release
To determine if DOPAC efflux could be used as an index of DA reuptake, the effect of the DA reuptake blocker, cocaine, was tested. Following the 1 h stabilization period, samples were collected at 5-rain intervals. After 4 baseline samples, 10 4 M cocaine was infused for 5 min (n = 5 superfusions). The basal release rates of DA and DOPAC were compared with release during the interval in which cocaine was infused into the chamber. Table I shows that, as expected, the longer the tissue was exposed to K + the more DA was released (F5.1~ = 5.91, P < 0.02). Interestingly, there was no relationship between the duration of exposure to K + and DOPAC efflux. Repeated depolarization of striatal tissue with 60 mM K + repeatedly stimulated the release of DA (Fig.  3A) , without influencing DOPAC levels in the effluent (Fig. 3B) .
Results
AMPH stimulated the release of DA in a clear dose-related manner when infused for either 1 min (F4.~ = 5.52, P < 0.004) or for 2.5 min (F4.~ = 9.74, P < 0.001: see Fig. 4 ). In addition, 25 min after AMPH stimulation, the K ~-stimulated release of DA was normal, with no influence of the preceeding dose of AMPH on the
TABLE I THE MEAN ( -+ S.E.M.) AMOUNT OF ENDOGENOUS DA AND DOPAC RELEASED (pg/mg/min) BEFORE AND AFTER THE INFUSION OF 60 mM KCI FOR DIFFERENT PERIODS OF TIME (n = 4 SUPERFUSIONS/GROUP)
Basal release is the mean of effluent samples 3 and 4, taken after the 1-h stabilization period, immediately before exposure to 60 mM KCI. K+-stimulated release is the mean of effluent samples 5 and 6, during and immediately after exposure to 60 mM KCI. K +-stimulated release differs from basal release: * P < 0.07, ** P < 0.02, *** P < 0.005 (2-tailed paired t-test). subsequent response to K +. Again, there was no relationship between the dose of AMPH and DOPAC efflux (F4j 8 = 2.5, P < 0.08). The basal rate of DA efflux was not Ca 2+ or temperature-dependent (Fig. 5) . As previously reported, we found that K +-stimulated DA release was both Ca 2+-and temperature-dependent, and that AMPH-stimulated DA release was temperature, but not CaZ+-dependent (Fig. 5) . DOPAC levels in the effluent were not affected by Ca 2+ or temperature. one-tailed). The increase in DA efflux was greater in magnitude than was the decrease in DOPAC efflux (t 4 = 2.94, P < 0.05, two-tailed).
Duration
Discussion
An in vitro superfusion chamber is described that is simple and inexpensive to construct, and easy to operate. To validate the use of this system the release of endogenous DA and DOPAC from striatal tissue was studied. Consistent with previous reports (Meyerhoff and Kant, 1978; Becket and Ramirez, 1980; Schwarz et al., 1980; Wightman et al., 1981) it was found that: (1) K+-stimulated release of DA is dose-, calcium-and temperature-dependent; and (2) AMPH-stimulated release of DA is dose-and temperature-dependent, but calcium-independent.
A potential problem with many in vitro systems for measuring neurotransmitter release is that drug-induced increases in the concentration of DA in the medium could result from either increased DA release or decreased DA reuptake. In the system described here, the concentration of DOPAC in the effluent allows one to determine if an increase in DA concentrations is the result of decreased DA reuptake. This is because DOPAC is primarily formed intraneuronally following DA reuptake (Cubeddu et al., 1979; Delanoy et al., 1982) . Therefore, if a drug blocks DA reuptake, the concentration of DOPAC would be expected to show a concomitant decline (Coyle and Snyder, 1969 : Heikkila et al., 1975 : Cubeddu et al., 1979 . We found that when reuptake was blocked with cocaine, there was a decrease in DOPAC efflux, but an even greater increase in DA efflux. We estimate that 57 ± 20% of the increased DA in the effluent was not accounted for by the decrease m DOPAC efflux.
In this superfusion system a decline in DOPAC efflux may indicate that DA reuptake is blocked, but substantial increases in DA reuptake are prevented by the medium flow. K*-induced depolarization produced only a very small elevation in DOPAC efflux, and there was no relation between the duration of K ~ stimulation and the levels of DOPAC. In contrast, if released DA is not immediately removed, as in an incubation system, K ~ stimulation greatly increases the efflux of both DA and DOPAC (Delanoy et al., 1982) . This indicates that the possible influence of DA reuptake on release is minimized with the superfusion system described here.
The mechanism by which AMPH increases DA concentrations extracellularly is not clearly understood and has been the subject of considerable speculation. The best available evidence suggests that AMPH primarily stimulates DA release, and that the reuptake blocking properties of AMPH are minimal (Heikkila et al., 1975; Moore, 1978; Fischer and Cho, 1979; Caviness et al., 1982) . In the studies reported here there was a strong relationship between the concentration of AMPH in the medium and the increase in DA concentrations in the effluent. However, there was no relationship between the magnitude of the AMPH-induced decrease in DOPAC efflux and the dose of AMPH. This supports the idea that the reuptake blocking properties of AMPH are not the primary mechanism through which DA concentrations in the effluent are increased.
It should be noted that the medium used in these experiments did not contain a monoamine oxidase (MAO) inhibitor, ascorbic acid or tyrosine; 3 compounds frequently included (Meyerhoff and Kant, 1978 : Becket and Ramirez, 1980 : Wightman et al., 1981 . In preliminary experiments we found that the inclusion of these agents (alone or in combination) did not affect the basal or AMPH-stimulated release of DA. However, DOPAC levels were dramatically decreased when a MAO inhibitor was included and increased when tyrosine was included. Because these agents did not facilitate the measurement of DA release, but clearly altered DA metabolism they were omitted from the medium.
The measurement of endogenous DA release avoids some of the potential problems with using radioactive tracers. For example, radioactive tracers may selectively label subcellular DA pools (Besson et al., 1969) , that may or may not be the most physiologically relevant pools. In addition, if slices are used, radioactive tracers may not be uniformly distributed throughout the tissue because the preloaded neurotransmitter must diffuse through the tissue prior to uptake. The use of synaptosomes alleviates the diffusion problem, but presents other problems related to the integrity of the release mechanism(s) in synaptosomes (Mulder, 1982) . Hopefully, the system described here will facilitate the use of superfusion systems for the measurement of endogenous DA and DOPAC release from the striatum to the extent that more researchers will consider the measurement of endogenous transmitter release over radiolabelled transmitter release.
